Oncotarget and its Founders’ Passion to Spread Awareness on Cancer and Treatments for It

The people behind Oncotarget has an advocacy to increase public awareness on the work that is being done by so many excellent oncologists around the world. They believe that as more and more people know about the progress of cancer treatment and the many types of it, it increases the value of the work done by their fellow oncologists and therefore making their work more efficient.

In the fight against one of the most fatal diseases on earth, increasing public awareness is essential especially as for most people; they only know that cancer treatment is expensive. But every week, oncologists are making progress in making cancer treatment more available and affordable for everyone, and this is what Oncotarget wants to highlight. Learn more about Oncotarget at researchgate.net

Oncotarget is an online journal which is open access to everyone. It is peer-reviewed by fellow oncologists, and per week, they release two issues. The editors-in-chiefs of Oncotarget themselves are both renowned Oncologists that have done much in the fight against cancer. They are Andrei V. Gudkov and Mikhail Blagosklonny. Mikhail is known for his work with the wonder drug ‘Rapamycin,’ and Andrei is known for his research on DNA repair. They feel that it is also their duty to highlight the clinical studies, publications, and trials made by their peers because they know there are many great oncologists out there whose work deserves to be highlighted to the public. Oncotarget is so serious about this advocacy that they even created a podcast which is available on iTunes, Stitcher, and Player.FM

Because of how the Oncotarget website was made, visitors can check peer-reviewed articles about Oncology and many other subjects, like studies about the process of aging and new treatments for different types of diseases, and these visitors never actually pay for that service. The Oncotarget articles are free to read, copy, paste, and share with your friends or with someone that you think will benefit from knowing about that particular study. Watch this video on Youtube.

The work of Oncotarget has revolutionized the way that the research field in Oncology works, as, now, one of the most visited websites in the field is free to read.

Learn more: https://www.ncbi.nlm.nih.gov/pmc/journals/1558/